CRYGN
Gamma-crystallin N
Also known as: CRGN_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WXF5
- Gene
- CRYGN
- Ensembl
- ENSG00000127377
- Chromosome
- 7
- Canonical length
- 182 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the crystallin family of proteins that are localized to the refractive structure of vertebrate eye lenses. The protein encoded by this gene is unique in that it has both beta and gamma crystallin protein motifs. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Canonical amino-acid sequenceUniProt
182 residues, UniProt reviewed canonical sequence.
>Q8WXF5|CRYGN
1 MAQRSGKITL YEGKHFTGQK LEVFGDCDNF QDRGFMNRVN SIHVESGAWV CFNHPDFRGQ
61 QFILEHGDYP DFFRWNSHSD HMGSCRPVGM HGEHFRLEIF EGCNFTGQCL EFLEDSPFLQ
121 SRGWVKNCVN TIKVYGDGAA WSPRSFGAED FQLSSSLQSD QGPEEATTKP ATTQPPFLTA
181 NLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRYGN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 15 nTPM
- seminal vesicle: 3.1 nTPM
- choroid plexus: 1.3 nTPM
- parathyroid gland: 1.2 nTPM
- pituitary gland: 1.1 nTPM
- cervix: 1 nTPM
Single-cell type
- decidual stromal cells: 9.2 nCPM
- retinal pigment epithelial cells: 8.5 nCPM
- pituicytes/fscs: 2.8 nCPM
- pituitary stem cells: 2.1 nCPM
- pericytes: 1.6 nCPM
- müller glia: 1.3 nCPM
Immune cell
- memory CD4 T-cell: 1.1 nTPM
- naive CD4 T-cell: 1.1 nTPM
- naive CD8 T-cell: 0.8 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- choroid plexus: 3.3 nTPM
- hippocampal formation: 2.4 nTPM
- amygdala: 2.3 nTPM
- cerebral cortex: 1.8 nTPM
- basal ganglia: 1.6 nTPM
- hypothalamus: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRYGN as an antibody target. Whether an autoantibody or antibody against CRYGN could matter depends on whether native CRYGN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRYGN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRYGN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...